학술논문
1661P Antitumor efficacy and immune profiling of the mouse ortholog of nemvaleukin alfa, a novel engineered IL-2 fusion protein, in an orthotopic mouse model of small cell lung cancer alone or in combination with standard chemotherapy
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1169-S1169
Subject
Language
ISSN
0923-7534